Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834115
Status:
UNKNOWN
Last Update Posted:
2021-04-06
First Post:
2021-03-28
Brief Title:
Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
Sponsor:
Universidad Nacional de Asunción
Organization:
Universidad Nacional de Asunción
Study Overview
Official Title:
Efficacy of Ivermectin in Outpatients With Non-severe COVID-19 A Randomized Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2021-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized controlled trial to evaluate the efficacy of ivermectin in reducing the risk of progression to severe disease and hospitalizations in COVID-19 patients
Detailed Description:
This is a randomized controlled trial to evaluate the efficacy of ivermectin in COVID-19 outpatients reducing the risk of progression to severe disease
Patients with COVID-19 infection are randomized to receive a single dose of 200mcgkg of ivermectin or a placebo
The randomization code is generated by the trial statistician The allocation is made after fulfilment of both inclusion and exclusion criteria
Patients with COVID-19 infection are randomized to receive a single dose of 200mcgkg of ivermectin or a placebo
The randomization code is generated by the trial statistician The allocation is made after fulfilment of both inclusion and exclusion criteria
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None